[Risk of hepatitis infection of the recipients of blood from donors with HBs-antigenemia].
Observations were made on 100 recipients of blood from 40 donors with HBs-antigenemia and 106 recipients of the control group, who had received 570 ampules of blood from 491 donors, and 499 ampules from 400 donors, respectively. The incidence of post-transfusion serum hepatitis in the icteric forms was 12.7% and 1.9%, respectively (P less than 0.002), varying between 8.9% and 22.2% in the experimental subgroups, and decreasing with the increase of the total number of blood transfusions received by the subjects. The source of infection proved to be 0.5% of the donors in the control group, and 2.65% in the experimental group (P less than 0.01), or 17.9-33.3%, of donors with HBs-antigenemia. With the sufficient number of recipients traced to each donor, all donors with HBs-antigenemia were found to be the sources of infection. It means that HBs-antigenemia may be regarded as the indication of the presence of the complete (infective) hepatitis virus B in the body.
D001782:Blood Donors; D002353:Carrier State / Q000453:epidemiology / Q000276:immunology*; D006509:Hepatitis B / Q000453:epidemiology* / Q000209:etiology; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006801:Humans; D012306:Risk; D065227:Transfusion Reaction; D014586:USSR
D006514:Hepatitis B Surface Antigens
Risk zabolevaniia gepatitom retsipientov krovi donorov s HBs-antigenemieĭ.